中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2013年
1期
26-28
,共3页
熊燕%张虹%陈炎添%容永璋
熊燕%張虹%陳炎添%容永璋
웅연%장홍%진염첨%용영장
多重耐药菌%耐药性%综合分析
多重耐藥菌%耐藥性%綜閤分析
다중내약균%내약성%종합분석
MDRB%Drug resistance%Meta-analysis
目的 分析多重耐药菌(MDRB)的分布特点及耐药性.方法 采用法国生物梅里埃ATB鉴定仪进行病原菌鉴定,K-B纸片扩散法进行药敏试验,同时根据来源追踪分析其易感因素.结果 9 954份标本中检出MDRB 811株,检出率8.1%;主要MDRB为大肠埃希菌、凝固酶阴性葡萄球菌、克雷伯菌、金黄色葡萄球菌、鲍曼不动杆菌、铜绿假单胞菌,后两者出现泛耐菌株;标本来源以呼吸道标本为主,占47.8%,主要分布于ICU病房,占41.8%;多重耐药肠杆菌对碳青霉烯类抗菌药物仍高度敏感,总耐药率<1.5%,对阿米卡星和酶抑制剂药物耐药率<30.0%;多重耐药非发酵菌则对碳青霉烯类抗菌药物总耐药率>77.0%,但对多黏菌素100.0%敏感和对头孢哌酮/舒巴坦保持较大的活性(耐药率<20.0%);多重耐药葡萄球菌对万古霉素、替考拉宁和利奈唑胺100.0%敏感,对氯霉素和利福平的耐药率相对较低(<30.0%);MDRB对其它抗菌药物呈现较高水平耐药;其易感因素包括高龄、基础疾病多、住院时间超过2周、使用多种广谱抗生素特别是三代头孢超过7d以上以及各种有创操作.结论 MDRB对常用抗菌药物耐药严重,临床医生应高度重视病原学检查和它们之间的耐药谱差异,根据药敏试验结果合理应用抗菌药物.
目的 分析多重耐藥菌(MDRB)的分佈特點及耐藥性.方法 採用法國生物梅裏埃ATB鑒定儀進行病原菌鑒定,K-B紙片擴散法進行藥敏試驗,同時根據來源追蹤分析其易感因素.結果 9 954份標本中檢齣MDRB 811株,檢齣率8.1%;主要MDRB為大腸埃希菌、凝固酶陰性葡萄毬菌、剋雷伯菌、金黃色葡萄毬菌、鮑曼不動桿菌、銅綠假單胞菌,後兩者齣現汎耐菌株;標本來源以呼吸道標本為主,佔47.8%,主要分佈于ICU病房,佔41.8%;多重耐藥腸桿菌對碳青黴烯類抗菌藥物仍高度敏感,總耐藥率<1.5%,對阿米卡星和酶抑製劑藥物耐藥率<30.0%;多重耐藥非髮酵菌則對碳青黴烯類抗菌藥物總耐藥率>77.0%,但對多黏菌素100.0%敏感和對頭孢哌酮/舒巴坦保持較大的活性(耐藥率<20.0%);多重耐藥葡萄毬菌對萬古黴素、替攷拉寧和利奈唑胺100.0%敏感,對氯黴素和利福平的耐藥率相對較低(<30.0%);MDRB對其它抗菌藥物呈現較高水平耐藥;其易感因素包括高齡、基礎疾病多、住院時間超過2週、使用多種廣譜抗生素特彆是三代頭孢超過7d以上以及各種有創操作.結論 MDRB對常用抗菌藥物耐藥嚴重,臨床醫生應高度重視病原學檢查和它們之間的耐藥譜差異,根據藥敏試驗結果閤理應用抗菌藥物.
목적 분석다중내약균(MDRB)적분포특점급내약성.방법 채용법국생물매리애ATB감정의진행병원균감정,K-B지편확산법진행약민시험,동시근거래원추종분석기역감인소.결과 9 954빈표본중검출MDRB 811주,검출솔8.1%;주요MDRB위대장애희균、응고매음성포도구균、극뢰백균、금황색포도구균、포만불동간균、동록가단포균,후량자출현범내균주;표본래원이호흡도표본위주,점47.8%,주요분포우ICU병방,점41.8%;다중내약장간균대탄청매희류항균약물잉고도민감,총내약솔<1.5%,대아미잡성화매억제제약물내약솔<30.0%;다중내약비발효균칙대탄청매희류항균약물총내약솔>77.0%,단대다점균소100.0%민감화대두포고동/서파탄보지교대적활성(내약솔<20.0%);다중내약포도구균대만고매소、체고랍저화리내서알100.0%민감,대록매소화리복평적내약솔상대교저(<30.0%);MDRB대기타항균약물정현교고수평내약;기역감인소포괄고령、기출질병다、주원시간초과2주、사용다충엄보항생소특별시삼대두포초과7d이상이급각충유창조작.결론 MDRB대상용항균약물내약엄중,림상의생응고도중시병원학검사화타문지간적내약보차이,근거약민시험결과합리응용항균약물.
Objective To provide an effective basis for clinical control methods of multi-drug-resistant bacterial (MDRB) infections by analyzing the distribution and antimicrobial resistance of MDRB.Methods The French Merieux ATB Expression Automated Analysis System was used for bacterial identification,whereas a drug susceptibility testing was performed by K-B methods.Drug-resistance rate was calculated,and the predisposing factors were analyzed.Results Altogether 811(8.1%) strains were isolated from 9 954 specimens,and the majority of multiply antimircobial-resistant bacteria were Escherichia coli,Coagulase-negative staphylococci,Klebsiella Pneumoniae Staphylococcus aureus,Acinetobacter Baumannii,Pseudommonas aeruginosa,whereas the last two appeared pan resistant strains.Specimen source was mainly from respiratory specimens,accounted for 47.8%,and was mainly distributed in the ICU unit,atout41.8% ;MDRB enterobacter was highly sensitive to Carbapenems with resistance rates less than 1.5% and to Amikacin and other inhibitor drugs that rate was less than 30.0%.The resistance rates of MDRB nonfermentative bacteria was > 77.0% to Carbapenem antibacterial drugs whereas to non-resistance was found to polymyxin and only 20.0% resistance rate to Cefoperazone/sulbactam.MDRB staphylococcus was 100.0% sensitive to Vancomyci,Teicoplanin and Linezolid and less sensitive (< 30.0%) to chloramphenicol and rifampicin.MDRB showed high resistance rate to other antibacterial drugs.The predisposing factors included age,other disease,hospitalization over two weeks,the usage of multiply antimicrobial especially cephalosporins overtoppinh 7 days,and invasive operations.Conclusion The major MDRBs are resistant to common-used antimicrobial drugs.It is nesessary to pay attention to the differences.